newsletter3

banner-about

Corporate Social Responsibility

Business with Social Responsibility
ViroGates recognizes that making a valuable contribution to society goes beyond research, development and marketing of new vital medical products. It starts within the company itself and is the heart of how we do business socially, ethically, environmentally and financially.

ViroGates subscribes to the UN's eight Millenium Development Goals and we take pride in the fact that our company and products can contribute to fulfilling three of these goals:

 Reduce infant and child mortality rates 1)
 Reduce the mortality rate amongst pregnant women 2)
 Stop the spread of HIV/AIDS, Malaria and other illnesses 3)

csr
Copyright Hanne Kjær, with kind permission

1) Nurhayati R et al. Role of soluble urokinase plasminogen activator receptor (suPAR) as prognosis markers of neonatal sepsis J Pharm Biol Sci; 2278-3008, Vol 6, Issue 5 (May. – Jun. 2013), PP 06-14
2) Toldi G, et al. Soluble urokinase plasminogen activator receptor (suPAR) levels in healthy pregnancy and preeclampsia, Clin Chem Lab Med. 2011 Nov;49(11):1873-6. doi: 10.1515/CCLM.2011.656. Epub 2011 Jul 4
3) Oliveirai. et al. Assessment of simple risk markers for early mortality among HIV-infected patients in Guinea-Bissau: a cohort study BMJ Open. 2012 Nov 14;2(6)

Contact us

virogates logo2
Blokken 45

3460 Birkerød
Denmark

Phone +45 21 13 13 36
Skype: virogates
CVR No.: 25734033
E-mail: info@virogates.com

 in-2  tw-2